Injectable Testosterone Cypionate — Individualized Testosterone Support
An individualized injectable testosterone cypionate protocol that can be titrated by symptoms, side effects, lab response, and dosing tolerance. In women, use in menopause-related care is typically off-label and requires careful monitoring.
Testosterone Cypionate Injection
A long-acting injectable testosterone ester that can be dosed once weekly or split twice weekly to improve tolerability or reduce breakthrough symptoms.
Women’s Use Considerations
Use of testosterone in women for menopausal sexual symptoms is typically individualized and off-label. Monitoring should prioritize symptom response and avoidance of androgen excess.
| Concentration | Starting Protocol | Frequency | Clinical Notes |
|---|---|---|---|
| 200 mg/mL | 0.05 mL | 1 to 2 times weekly | Titrate to symptoms and side effects |
| 100 mg/mL | 0.1 mL | 1 to 2 times weekly | Titrate to symptoms and side effects |
| 50 mg/mL | 0.2 mL | 1 to 2 times weekly | Titrate to symptoms and side effects |
Start with once-weekly dosing. Consider twice-weekly dosing for breakthrough symptoms, side effects, or poor tolerance of the desired weekly dose.
- Monitor clinical response, androgenic side effects, and relevant laboratory markers over time.
- In women, testosterone therapy should be used cautiously and typically for sexual desire disorders after shared decision-making.
- Split dosing may smooth peaks and troughs in selected patients.
- Monitor for acne, hirsutism, voice change, scalp hair shedding, and supraphysiologic levels.
Testosterone cypionate is an oil-based ester of testosterone that is hydrolyzed after injection to provide androgen activity over time. In tissues, testosterone may also convert to dihydrotestosterone and interact with androgen receptors that influence sexual function, energy, body composition, and other androgen-responsive systems.
- Known hypersensitivity to testosterone cypionate or formulation components
- Known or suspected prostate cancer or male breast cancer in labeled male use
- Pregnancy or potential pregnancy because testosterone can cause fetal harm
- Serious cardiac, hepatic, or renal disease in labeled product warnings
Monitoring concerns: Polycythemia, edema, lipid or blood pressure changes, VTE, androgenic adverse effects, and injection-site issues should be reviewed.
- Store at controlled room temperature. Do not refrigerate unless specifically instructed by the pharmacy.
- Protect from light. If crystallization occurs, warming the vial gently to room temperature may help redissolve the medication.
- The medicine should be fine for 5 days from the shipping date at temperatures up to 105 degrees Fahrenheit.
Why split the dose twice weekly?
Some patients tolerate smaller, more frequent doses better and experience fewer peaks and troughs.
Is this FDA-approved for women?
Testosterone products are generally labeled for male hypogonadism. Female use is typically off-label and should be individualized carefully.
Partner with Genesis Compounding
A 503A-licensed compounding partner built for telehealth and physician practice workflows. Download your onboarding documents below to get started.
Fax completed forms to 385-855-1221 or email pharmacy@genesiscompounding.com